NEW YORK (GenomeWeb News) – Sequenom today said that it has launched a certified service program for its MassArray System and has named the first laboratory participants.
NewGene has launched a sequencing-based test on Roche's 454 GS FLX for Noonan syndrome and other related disorders.
NewGene's hereditary breast cancer test
NewGene is initially targeting the UK market and patients with an increased hereditary risk for breast cancer for its pyrosequencing-based assay.
The UK firm will provide services for NimbleGen Sequence Capture Arrays with sequencing on Roche 454's Genome Sequencer FLX System.
The company expects to use Roche's 454 technology to offer full-gene sequencing tests at a lower cost and faster turnaround time than existing providers using Sanger sequencing.
David Huntley, Ann Curtis, Jonathan Robinson, Jonathan Coxhead, David Allison, John Burn, Michael Wright, Kary Mullis
Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.
The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.
Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.
In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.